Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board Appointment

2 Feb 2009 11:01

RNS Number : 6266M
Plant Health Care PLC
02 February 2009
 



02 February 2009

Plant Health Care plc

("Plant Health Care" or "the Company")

NEW BOARD APPOINTMENT

Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscape industries, announces that Dr. Dominik Koechlin was appointed to its Board as a non-executive director on 30 January 2009.

Dr. Koechlin, 50, a Swiss national, graduated from the University of Berne with a doctorate in law. He also has an MBA from INSEAD, Fontainebleau, France. Dr. Koechlin is currently a non-executive director of LGT Bank in Liechtenstein, and the following Swiss-listed companies: EGL AG, Swissmetal AG and Clariant AG.

Dr. Koechlin began his career working at Bank Sarasin in Basel from 1986 to 1988. He founded Ellipson AG in 1990, a business and management consultancy specialised in environmentally sound management and corporate financing. From 1996, he was a member of the executive committee of Telecom PTT and Swisscom AG.

During his time at Swisscom, the leading telecommunications provider in Switzerland, Dr. Koechlin was responsible for the redesign of the Swisscom business model, preparation for the IPO of Swisscom and development and communication of corporate strategy, as well as the international participations of Swisscom. Since 2001, Dr. Koechlin has worked as an independent board member and consultant for a number of listed and private businesses.

Dr. Albert Fischer, Non-executive Chairman of Plant Health Care commented:: "Dr. Koechlin has a great deal of experience in advising profitable, high-growth listed companies and will be a very strong addition to the Plant Health Care Board."

There is no other information that is required to be disclosed pursuant to Schedule 2 paragraph (g) of the AIM Rules, save as set out below:

Dominik Koechlin

Current Directorships

Past Directorships within last 5 years

LGT Bank in Liechtenstein Limited

Crucell NV

Elektrizitäts-Gesellschaft Laufenburg AG

Sustainable Asset Management AG

Swissmetal AG

Berna Biotech AG

Clariant AG

Novavox AG

Avaloq AG

Hesperion AG

M2 AG

Corris AG

- ends -

For further information:

John Brady

Evolution Securities Limited

Tavistock Communications

Chief Executive

Tim Worlledge/Tim Redfern

Jeremy Carey/Simon Compton

Tel: 001 603 525 3702

Tel: 020 7071 4300

Tel: 020 7920 3150

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAILFEIFAIFIIA
Date   Source Headline
3rd Aug 20177:00 amRNSHolding(s) in Company
12th Jul 20174:09 pmRNSGrant of options
30th Jun 20173:30 pmRNSHolding(s) in Company
15th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20174:35 pmRNSPrice Monitoring Extension
6th Jun 20177:00 amRNSNew Technology Update
31st May 20177:00 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSDirector/PDMR Shareholding
22nd May 20177:00 amRNSGrant of options
11th May 201712:50 pmRNSResult of AGM
27th Apr 20177:00 amRNSPublication of Annual Report and Notice of AGM
10th Apr 20177:00 amRNSResults for the Year Ended 31 December 2016
5th Apr 20174:49 pmRNSChange of Registered Office
5th Apr 20177:00 amRNSHolding(s) in Company
5th Apr 20177:00 amRNSHolding(s) in Company
20th Feb 20177:01 amRNSDirector/PDMR Shareholding
20th Feb 20177:00 amRNSBlock listing Interim Review
8th Feb 20177:00 amRNSHolding(s) in Company
18th Jan 20177:02 amRNSResearch Update
18th Jan 20177:00 amRNSTrading Statement
19th Dec 20164:40 pmRNSSecond Price Monitoring Extn
19th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20164:40 pmRNSSecond Price Monitoring Extn
14th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20167:00 amRNSNew Commercial Distribution Agreements
30th Nov 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSDirectorate Change
14th Sep 20167:00 amRNSHalf-year Report
31st Aug 20164:30 pmRNSTotal Voting Rights
23rd Aug 20162:54 pmRNSHolding(s) in Company
23rd Aug 20167:00 amRNSBlock listing Interim Review
23rd Aug 20167:00 amRNSDirector/PDMR Shareholding
22nd Aug 20163:44 pmRNSHolding(s) in Company
22nd Aug 20163:38 pmRNSHolding(s) in Company
16th Aug 201611:41 amRNSResult of General Meeting, Placing & Open Offer
29th Jul 20167:00 amRNSProposed Placing, Subscription and Open Offer
7th Jun 20167:00 amRNSProgress on New Technology Builds Momentum
23rd May 20163:09 pmRNSResult of AGM
17th May 20163:45 pmRNSChange of Registered Office Address
25th Apr 20167:00 amRNSAnnual Financial Report
8th Apr 20167:00 amRNSAnnual Financial Report
22nd Feb 20167:00 amRNSBlocklisting Interim Review
2nd Feb 20167:00 amRNSReduced Disclosure Framework
29th Jan 20167:00 amRNSTrading Statement
2nd Dec 20157:00 amRNSPHC Expands Distribution Agreement with Sym-Agro
1st Dec 20157:00 amRNSPHC notification of major interest in shares
30th Nov 20157:00 amRNSPHC and Arysta LifeScience Terminate Agreement
30th Oct 20151:21 pmRNSTotal Voting Rights
30th Sep 20153:47 pmRNSTotal Voting Rights
25th Sep 20157:00 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.